These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 410362

  • 1. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.
    Parsley TL, Provonchee RB, Glicksman C, Zinner SH.
    Antimicrob Agents Chemother; 1977 Sep; 12(3):349-52. PubMed ID: 410362
    [Abstract] [Full Text] [Related]

  • 2. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
    Van Laethem Y, Husson M, Klastersky J.
    Antimicrob Agents Chemother; 1984 Aug; 26(2):224-7. PubMed ID: 6435515
    [Abstract] [Full Text] [Related]

  • 3. Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli.
    Zinner SH, Provonchee RB, Elias KS, Peter G.
    Antimicrob Agents Chemother; 1976 Apr; 9(4):661-4. PubMed ID: 817663
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD, Pasiecznik K.
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E, Schoutens E, Vanderlinden MP.
    Chemotherapy; 1975 Dec; 21(1):45-51. PubMed ID: 807457
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
    Kurtz TO, Winston DJ, Bruckner DA, Martin WJ.
    Antimicrob Agents Chemother; 1981 Aug; 20(2):239-43. PubMed ID: 6792982
    [Abstract] [Full Text] [Related]

  • 7. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Van der Auwera P, Klastersky J, Lieppe S, Husson M, Lauzon D, Lopez AP.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
    [Abstract] [Full Text] [Related]

  • 8. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.
    Lagast H, Pascual-Lopez A, Dejace P, Klastersky J.
    Eur J Clin Microbiol; 1986 Feb; 5(1):98-102. PubMed ID: 3084248
    [Abstract] [Full Text] [Related]

  • 9. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD, Steffens A, Langmaack H.
    Chemotherapy; 1979 Feb; 25(5):282-5. PubMed ID: 113178
    [Abstract] [Full Text] [Related]

  • 10. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
    Rahal JJ, Simberkoff MS, Kagan K, Moldover NH.
    Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
    Moody JA, Fasching CE, Peterson LR, Gerding DN.
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):59-67. PubMed ID: 3100127
    [Abstract] [Full Text] [Related]

  • 12. Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Van Laethem Y, Klastersky J.
    Eur J Clin Microbiol; 1986 Feb; 5(1):110-4. PubMed ID: 3084239
    [Abstract] [Full Text] [Related]

  • 13. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH.
    Infection; 1976 Feb; 4(2):35-41. PubMed ID: 789246
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.
    Lagast H, Klastersky J, Standiford H, Viollier A.
    Infection; 1984 Feb; 12(3):190-3. PubMed ID: 6432702
    [Abstract] [Full Text] [Related]

  • 15. Patterns and mechanisms of emergence of resistance to amikacin.
    Meyer RD.
    J Infect Dis; 1977 Sep; 136(3):449-52. PubMed ID: 409785
    [Abstract] [Full Text] [Related]

  • 16. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
    Greenberg RN, Bollinger M, Compton J.
    Clin Ther; 1986 Sep; 8(3):354-8. PubMed ID: 3087621
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ, Simberkoff MS, Rahal JJ.
    J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
    [Abstract] [Full Text] [Related]

  • 18. Bactericidal activity of amikacin and gentamicin.
    Shah RM, Heetderks G, Stille W.
    Chemotherapy; 1977 Aug; 23(4):260-6. PubMed ID: 405182
    [Abstract] [Full Text] [Related]

  • 19. Aminoglycoside antibiotics. IX. 1-N-acyl derivatives of kanamycin A (amikacin analogs).
    Naito T, Nakagawa S, Narita Y, Toda S, Abe Y.
    J Antibiot (Tokyo); 1974 Nov; 27(11):851-8. PubMed ID: 4217789
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N, Oguri T.
    Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.